SOSTDC1: Regulating Neuronal Communication and Cellular Signaling Pathways

Target Name: SOSTDC1

NCBI ID: G25928

SOSTDC1

SOSTDC1: Regulating Neuronal Communication and Cellular Signaling Pathways

SOSTDC1 (Sostylized activin receptor type C1) is a protein that is expressed in various tissues throughout the body. It is a member of the activin receptor family, which includes proteins that are involved in cell signaling and growth. SOSTDC1 is primarily expressed in the brain, and it has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease and Parkinson's disease.

One of the key functions of SOSTDC1 is its role in the regulation of neurotransmitter release from neurons. This is done through the interaction between SOSTDC1 and a protein called TRPV1. TRPV1 is a receptor that is involved in the sensation of pain and temperature, and it is thought to play a role in the development of chronic pain. By interacting with SOSTDC1, TRPV1 allows SOSTDC1 to regulate the release of neurotransmitters, such as dopamine and serotonin, from neurons.

Another function of SOSTDC1 is its role in the regulation of neurogenesis. This is done through the interaction between SOSTDC1 and a protein called GFR伪1. GFR伪1 is a receptor that is involved in the uptake of neurotransmitters, and it is thought to play a role in the development of neuroplasticity. By interacting with SOSTDC1, GFR伪1 allows SOSTDC1 to regulate the production of new neurons in the brain.

In addition to its role in neurotransmission and neurogenesis, SOSTDC1 is also involved in the regulation of cellular signaling pathways. This is done through the interaction between SOSTDC1 and a protein called Pyruvatecarrier. Pyruvatecarrier is a protein that is involved in the metabolism of pyruvate, a molecule that is used as a source of energy by cells. By interacting with SOSTDC1, Pyruvatecarrier allows SOSTDC1 to regulate the production of ATP, which is a source of energy for cellular signaling pathways.

SOSTDC1 is also involved in the regulation of inflammation. This is done through the interaction between SOSTDC1 and a protein called NF-kappa-B. NF-kappa-B is a protein that is involved in the regulation of inflammation and immune responses, and it is thought to play a role in the development of various inflammatory disorders. By interacting with SOSTDC1, NF-kappa-B allows SOSTDC1 to regulate the production of pro-inflammatory cytokines, which can contribute to inflammation.

SOSTDC1 is also involved in the regulation of cellular signaling pathways that are involved in cell adhesion and migration. This is done through the interaction between SOSTDC1 and a protein called E-cadherin. E-cadherin is a protein that is involved in the regulation of cell adhesion and migration, and it is thought to play a role in the development of various diseases, including cancer. By interacting with SOSTDC1, E-cadherin allows SOSTDC1 to regulate the production of adhesion molecules, which are involved in cell adhesion and migration.

In conclusion, SOSTDC1 is a protein that is involved in a variety of cellular signaling pathways that are important for the development and progression of various neurological disorders. Its role in neurotransmission and neurogenesis, as well as its involvement in the regulation of cellular signaling pathways and inflammation, make SOSTDC1 an attractive drug target or biomarker for future research. Further studies are needed to fully understand the role of SOSTDC1 in these processes and to develop effective therapies for the treatment of neurorological disorders.

Protein Name: Sclerostin Domain Containing 1

Functions: May be involved in the onset of endometrial receptivity for implantation/sensitization for the decidual cell reaction Enhances Wnt signaling and inhibits TGF-beta signaling (By similarity). Directly antagonizes activity of BMP2, BMP4, BMP6 and BMP7 in a dose-dependent manner

The "SOSTDC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOSTDC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets